To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min It’s another sign of how ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The proposed townhome ...

An elite Iranian military unit plotted to assassinate the Israeli ambassador to Mexico, according to a US official familiar with the matter. The plan, hatched by the Iranian Revolutionary Guard Corps’ ...

CSL Seqirus, the vaccine unit of Australian biotech CSL, has signed a pact to provide Saudi Arabia with cell-based influenza shots and help establish its production in-country. The move forms part of ...

Galapagos (NASDAQ:GLPG) ADRs dropped ~13% in the premarket on Tuesday after the Belgian biotech announced plans to wind down its cell therapy business, impacting roughly 365 employees in Europe, the U ...

Galapagos is planning to wind down its cell therapy business, completing a whiplash change that saw the biotech go from focusing on the modality to ditching it in six months. Belgium-based Galapagos ...

Oct 10 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab has decided to discontinue its cell therapy research and development efforts, a spokesperson for the Danish drugmaker told Reuters on Friday.

Ozempic maker Novo Nordisk (NVO) is closing its cell therapy division as part of a major restructuring drive initiated under the company’s new CEO, Mike Doustdar, Bloomberg News reported on Thursday, ...

Novo Nordisk is ending all work in cell therapy, including a Type 1 diabetes program, amid CEO Maziar Mike Doustdar's reorganization. As part of the move, the company is laying off nearly all of the ...

Despite finally opening a long-planned alternative to its old isolation cells this year, Oregon’s largest youth prison continues to use its 1950s-era Intervention Unit nicknamed the “dungeon” and has ...

Aug 21 (Reuters) - Gilead Sciences' (GILD.O), opens new tab unit Kite Pharma said on Thursday it will acquire privately-held biotech firm Interius BioTherapeutics for $350 million in cash to advance ...

Thomas Dohmke, chief executive of Microsoft Corp.’s GitHub unit, today announced plans to step down. Axios reported that the tech giant doesn’t plan to appoint a new CEO for the business. Instead, it ...